The Executive Director, Regulatory Affairs Liaison reports to the Vice President (VP), General Medicine, and is accountable for defining and executing global regulatory strategy for assigned ophthalmology programs
Job Summary
The Executive Director, Regulatory Affairs Liaison reports to the Vice President (VP), General Medicine, and is accountable for defining and executing global regulatory strategy for assigned ophthalmology programs.
The role provides strategic oversight across ophthalmology programs in the General Medicine Therapeutic Area, ensuring regulatory objectives are aligned with development, evidence-generation, and commercialization priorities.
The successful candidate will be eligible for annual bonus and long-term incentive, if applicable, and offered a comprehensive package of benefits including medical, dental, vision, retirement, paid holidays, vacation, and sick days.
Matching Summary
The Executive Director, Regulatory Affairs Liaison reports to the Vice President (VP), General Medicine, and is accountable for defining and executing global regulatory strategy for assigned ophthalmology programs.
Salary
$231,900.00 - $365,000.00; Bonus/Equity: Annual bonus and long-term incentive, if applicable; Benefits: Medical, dental, vision healthcare and other insurance benefits (for employee and family), retirement benefits, including 401(k), paid holidays, vacation, and compassionate and sick days.
Skills & Requirements
Must-have
global regulatory strategy
ophthalmology drug development
regulatory authority engagement
leading high-performing teams
securing original NDA/BLA approvals
Nice-to-have
intellectual curiosity
growth mindset
rigor and professionalism
cross-cultural awareness
business development
Key Requirements
Minimum 12 years drug development experience (majority in regulatory affairs) with B.S./M.S.
Minimum 9 years drug development experience (at least 7 in regulatory) with M.D./Ph.D. or PharmD.
Demonstrated success in securing original NDA/BLA approvals
Extensive experience in U.S. and international regulatory affairs